Login / Signup

Prognosis according to the timing of recurrence in breast cancer.

Young Joo LeeSeung-Pil JungJeoung Won BaeSun Moon YangJi Young YouSoo Youn Bae
Published in: Annals of surgical treatment and research (2023)
The luminal B subtype had a high rate of late recurrence, and late recurrence was a poor prognostic factor for OS only in this subgroup. Therefore, further targeted treatments for luminal B breast cancer are needed and patients with this subtype require close long-term surveillance.
Keyphrases
  • prognostic factors
  • free survival
  • public health
  • randomized controlled trial
  • drug delivery
  • double blind